Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06685692
PHASE2

A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)

Sponsor: Aldeyra Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Moderate Alcohol Associated Hepatitis (Part 1)

Official title: A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects With Moderate Alcohol Associated Hepatitis

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

4

Start Date

2024-11-04

Completion Date

2025-06-18

Last Updated

2026-06-03

Healthy Volunteers

No

Interventions

DRUG

ADX-629

125 mg twice daily for 28 days

DRUG

ADX-629

250 mg twice daily for 28 days

Locations (6)

Synergry Healthcare

Bradenton, Florida, United States

Florida Health Sciences Center/Tampa General Hospital/USF

Tampa, Florida, United States

The Liver Institute at Methodist Dallas Medical Center

Dallas, Texas, United States

UDL Clinical Research, LLC

Houston, Texas, United States

Methodist Specialty and Transplant Hospital

San Antonio, Texas, United States

Bon Secours Liver Institute of Newport News

Richmond, Virginia, United States